Takeda Pharmaceutical Company Limited

Anne Goldby

Martin Teall

Colm Carroll

Kerry Jenkins

Natasha Kinsella

Sarah Bousba

William John Farnaby

Richard John Davenport

David Harrison

Gregory Barker

Robert Downham

Duncan Hannah

Henriette Willems

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. in which q, R, R, Rand Rare as defined in the specification, for use in therapy.

Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R, R, Rand Rare as defined in the specification, for use in therapy.

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, in which R, R, R, Rand Rare as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy. 

Piperidine derivatives for use in the treatment or prevention of psychiatric and neurological conditions

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R, R, Rand Rare as defined in the specification, processes for their preparation, pharmaceutical compositions N containing them and their use in therapy. 

Piperidine and azepine derivatives as prokineticin receptor modulators

The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X, XX, X, R, R, Rand Rare as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy. 

3-substituted 2-amino-indole derivatives

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof (Formula (I)) in which m, X, R, R, Rand Rare as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy. 

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof: (I) in which m, n, W, X, Y, Z, R, R, Rand Rare as defined in the specification, for use in the treatment or prevention of a diseases o conition mediated by a prokineticin, such as psychiatric and neurological conditions. 

Growing community of inventors

Cambridgeshire, United Kingdom

Anne Goldby